Breakfast Innovation Theater (Non-Accredited): An Established Antipsychotic, Now Available as a Subcutaneous Injection

Breakfast will be served. Seating is limited to 150 and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs. Presenter(s): Erin Crown, MHS, PA-C, CAQ-Psychiatry This presentation is sponsored by Teva Pharmaceuticals, Inc.